Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jun;33(6):857–861. doi: 10.1128/aac.33.6.857

Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.

L S Welage 1, L G Hejmanowski 1, J H Wilton 1, C Walawander 1, D Rigan 1, J S Williams 1, J J Schentag 1
PMCID: PMC284245  PMID: 2764537

Abstract

The N-methylthiotetrazole side chain (NMTT) that is present on several cephalosporins has been implicated in the development of antibiotic-associated hypoprothrombinemia. A randomized three-way crossover trial was conducted to compare the release of the NMTT side chain from three NMTT-containing antibiotics. Single 2-g doses of moxalactam, cefoperazone, and cefotetan were given, followed by serial blood and urine sampling. The concentrations of the parent compound and the NMTT side chain in plasma, urine, and the reconstituted antibiotic solution were determined by high-pressure liquid chromatography. Peak NMTT concentrations ranged from 0.42 to 16.50 micrograms/ml and were significantly higher after moxalactam administration than after cefoperazone or cefotetan administration (P less than 0.01). The NMTT trough concentrations (12.5 h) ranged from nondetectable to 2.47 micrograms/ml and tended to be greater following cefoperazone administration. The amounts of NMTT administered (e.g., the amount in the reconstituted antibiotic solution) were 25.8 +/- 1.4, 15.2 +/- 0.9, and 22.1 +/- 3.0 mg following moxalactam, cefoperazone, and cefotetan administration, respectively (P less than 0.01). In contrast, urinary recoveries of NMTT were 57.4 +/- 26.2, 73.6 +/- 44.3, and 29.7 +/- 22.9 mg following moxalactam, cefoperazone, and cefotetan, respectively. The amount of NMTT formed in vivo and excreted unchanged, as assessed by subtracting in vitro NMTT formation from NMTT urinary recovery, was significantly higher after cefoperazone than after moxalactam or cefotetan administration (P less than 0.05). The discrepancy between in vitro NMTT production (moxalactam > cefotetan > cefoperazone) and the amount of NMTT formed in vivo and excreted unchanged (cefoperazone > moxalactam > cefotetan) demonstrated that the in vivo production of NMTT is dependent on the disposition of the parent cephalosporin.

Full text

PDF
857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronoff G. R., Wolen R. L., Obermeyer B. D., Black H. R. Pharmacokinetics and protein binding of cefamandole and its 1-methyl-1 H-tetrazole-5-thiol side chain in subjects with normal and impaired renal function. J Infect Dis. 1986 Jun;153(6):1069–1074. doi: 10.1093/infdis/153.6.1069. [DOI] [PubMed] [Google Scholar]
  2. Baxter J. G., Marble D. A., Whitfield L. R., Wels P. B., Walczak P., Schentag J. J. Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin. Ann Surg. 1985 Jan;201(1):96–102. [PMC free article] [PubMed] [Google Scholar]
  3. Bechtold H., Andrassy K., Jähnchen E., Koderisch J., Koderisch H., Weilemann L. S., Sonntag H. G., Ritz E. Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost. 1984 Jul 29;51(3):358–361. [PubMed] [Google Scholar]
  4. Creedon K. A., Suttie J. W. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase. Thromb Res. 1986 Oct 15;44(2):147–153. doi: 10.1016/0049-3848(86)90130-1. [DOI] [PubMed] [Google Scholar]
  5. Lipsky J. J. Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics. Proc Natl Acad Sci U S A. 1984 May;81(9):2893–2897. doi: 10.1073/pnas.81.9.2893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lipsky J. J. N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia. Lancet. 1983 Jul 23;2(8343):192–193. doi: 10.1016/s0140-6736(83)90174-5. [DOI] [PubMed] [Google Scholar]
  7. Mackie I. J., Walshe K., Cohen H., McCarthy P., Shearer M., Scott S. D., Karran S. J., Machin S. J. Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations. J Clin Pathol. 1986 Nov;39(11):1245–1249. doi: 10.1136/jcp.39.11.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schentag J. J., Welage L. S., Grasela T. H., Adelman M. H. Determinants of antibiotic-associated hypoprothrombinemia. Pharmacotherapy. 1987;7(3):80–86. doi: 10.1002/j.1875-9114.1987.tb03522.x. [DOI] [PubMed] [Google Scholar]
  9. Schentag J. J., Welage L. S., Williams J. S., Wilton J. H., Adelman M. H., Rigan D., Grasela T. H. Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety. Am J Surg. 1988 May 31;155(5A):40–44. doi: 10.1016/s0002-9610(88)80210-1. [DOI] [PubMed] [Google Scholar]
  10. Shearer M. J., Bechtold H., Andrassy K., Koderisch J., McCarthy P. T., Trenk D., Jähnchen E., Ritz E. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol. 1988 Jan;28(1):88–95. doi: 10.1002/j.1552-4604.1988.tb03106.x. [DOI] [PubMed] [Google Scholar]
  11. Smith G. F., Sundboom J. L. The effects of 1-methyl-5-thiotetrazole in a rat liver vitamin K-dependent carboxylase assay. Thromb Res. 1984 Mar 15;33(6):633–644. doi: 10.1016/0049-3848(84)90118-x. [DOI] [PubMed] [Google Scholar]
  12. Suttie J. W., Engelke J. A., McTigue J. Effect of N-methyl-thiotetrazole on rat liver microsomal vitamin K-dependent carboxylation. Biochem Pharmacol. 1986 Jul 15;35(14):2429–2433. doi: 10.1016/0006-2952(86)90472-7. [DOI] [PubMed] [Google Scholar]
  13. Suttie J. W. Recent advances in hepatic vitamin K metabolism and function. Hepatology. 1987 Mar-Apr;7(2):367–376. doi: 10.1002/hep.1840070226. [DOI] [PubMed] [Google Scholar]
  14. Uchida K., Ishigami T., Komeno T. Effects of latamoxef and methyltetrazolethiol on gamma-glutamylcarboxylase activity. Jpn J Pharmacol. 1984 Jul;35(3):330–333. doi: 10.1254/jjp.35.330. [DOI] [PubMed] [Google Scholar]
  15. Wise R., Dent J. Stability of beta-lactam antibiotics containing N-methylthiotetrazole side-chain. Lancet. 1983 Sep 10;2(8350):624–625. doi: 10.1016/s0140-6736(83)90708-0. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES